Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen total Common Stock Dividends Declared ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity (XBRL)
Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
21 quarters
Since Q1 2018
Sources
13
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Common Stock Dividends Declared ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 0 | – | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,362 | +6.4% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,640 | +6.2% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,308 | +5.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 0 | – | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,280 | +6.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,487 | – | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,236 | +6.5% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 0 | – | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,208 | +6.2% | Form 10-Q (filed 2025-05-02) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,161 | +9.8% | Form 10-Q (filed 2024-10-31) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,138 | +10.1% | Form 10-Q (filed 2024-10-31) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,057 | +3.9% | Form 10-Q (filed 2023-10-31) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,034 | +2.2% | Form 10-Q (filed 2023-10-31) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,017 | +6.8% | Form 10-Q (filed 2022-11-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,012 | +7.9% | Form 10-Q (filed 2022-11-04) ↗ |
| Q3 2020 | Sep 30, 2020 | 952 | +8.2% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2020 | Mar 31, 2020 | 938 | +6.7% | Form 10-Q (filed 2021-11-03) ↗ |
| Q3 2019 | Sep 30, 2019 | 880 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 879 | +0.2% | Form 10-Q (filed 2020-05-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 877 | – | Form 10-Q (filed 2019-10-30) ↗ |
Cite this data
StockData. (2026). Amgen Total Common Stock Dividends Declared ($M) ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/div_decl_tot
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.